What is PHAR's relative strength rating?

PHAR ranks at the 19th percentile over 1 month, 31th percentile over 3 months, 16th percentile over 6 months, 37th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is PHAR in?

PHAR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is PHAR in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). PHAR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is PHAR?

PHAR currently shows a 20-day average daily range (ADR%) of 5.7%, a 90-day beta versus the S&P 500 of 0.67. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does PHAR have a seasonal pattern?

TickerStance computes PHAR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what PHAR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did PHAR last report earnings?

No SEC EDGAR filings are linked to PHAR in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Pharming Group N.V. ADS, each representing 10 ordinary...

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) has a 3-month relative strength percentile of 31 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 43. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.7%, relative volume 0.97×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month31pctile

6 month16pctile

1 year37pctile

Classic22IBD pctile

LDR38leadership

0 of 5 lenses lit · avg RS pctile 29

✓ADR%5.7%✓A/DB!RVOL0.97×!$ Vol$162K

COMPUTED · AS OF 2026-08-24

Pattern read

PHAR is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -8.8% / -25.0%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

19

3m

31

6m

16

1y

37

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · PHAR

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
PHAR
31RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

QDELQuidelOrtho Corporation Common Stock16 RNTXRein Therapeutics, Inc. Common Stock16 ENVBEnveric Biosciences, Inc. Common Stock16 PAHCPhibro Animal Health Corporation Class A16

§ Seasonality

10y · since 2022

Best monthAug on averageavg +22.59% · 75% win · n 4

Worst monthFeb on averageavg -10.02% · 0% win · n 4

PHAR monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	PHAR Jan avg: 8.91% median: 13.70% win: 75% σ: 15.11% n: 4 2022-04-13 → 2026-07-31	PHAR Feb avg: -10.02% median: -9.40% win: 0% σ: 8.00% n: 4 2022-04-13 → 2026-07-31	PHAR Mar avg: 0.91% median: -0.77% win: 50% σ: 7.12% n: 4 2022-04-13 → 2026-07-31	PHAR Apr avg: -5.55% median: -4.50% win: 20% σ: 8.64% n: 5 2022-04-13 → 2026-07-31	PHAR May avg: -0.22% median: -2.07% win: 40% σ: 15.80% n: 5 2022-04-13 → 2026-07-31	PHAR Jun avg: 0.77% median: 0.85% win: 60% σ: 6.91% n: 5 2022-04-13 → 2026-07-31	PHAR Jul avg: -6.76% median: -0.24% win: 40% σ: 13.41% n: 5 2022-04-13 → 2026-07-31	PHAR Aug avg: 22.59% median: 19.52% win: 75% σ: 29.92% n: 4 2022-04-13 → 2026-07-31 (current)	PHAR Sep avg: -5.90% median: -6.07% win: 25% σ: 10.99% n: 4 2022-04-13 → 2026-07-31	PHAR Oct avg: 0.21% median: 1.26% win: 50% σ: 7.65% n: 4 2022-04-13 → 2026-07-31	PHAR Nov avg: 10.51% median: 12.99% win: 50% σ: 24.61% n: 4 2022-04-13 → 2026-07-31	PHAR Dec avg: 6.35% median: -0.03% win: 50% σ: 21.11% n: 4 2022-04-13 → 2026-07-31

Public attention · PHAR

Is the crowd watching?

49/ 100 · vs its own 90-day norm▼ 12 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out70.8Mshares

Market cap$811.1MSmall Cap

FAQ

Frequently asked questions

What is PHAR's relative strength rating?: PHAR ranks at the 19th percentile over 1 month, 31th percentile over 3 months, 16th percentile over 6 months, 37th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is PHAR in?: PHAR is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is PHAR in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). PHAR benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is PHAR?: PHAR currently shows a 20-day average daily range (ADR%) of 5.7%, a 90-day beta versus the S&P 500 of 0.67. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does PHAR have a seasonal pattern?: TickerStance computes PHAR's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what PHAR has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) — Stance & relative strength

PHAR is not confirmed as a leader. 31 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?